Related Experiment Videos
Hirsutism: diagnosis and management.
1Ambulatory Center, University of Rochester Medical Center, 601 Elmwood Ave, Box 697, Rochester, NY 14642, USA.
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia
|August 2, 2001
Summary
Hirsutism, or excess hair growth in women, often has no hormonal cause. However, a new topical medication, eflornithine hydrochloride, offers a safe, effective treatment option with no systemic side effects.
Area of Science:
- Endocrinology
- Dermatology
Background:
- Hirsutism affects many women, with most cases being idiopathic (no underlying hormonal cause).
- A subset of women experience hirsutism due to hormonal imbalances, necessitating careful diagnosis.
- The condition significantly impacts quality of life, driving the need for improved treatments.
Purpose of the Study:
- To review the management of hirsutism.
- To highlight the benefits of topical eflornithine hydrochloride for hirsutism treatment.
Main Methods:
- Review of current literature on hirsutism.
- Evaluation of the efficacy and safety of eflornithine hydrochloride.
Main Results:
- Idiopathic hirsutism is common, with normal androgen levels.
- Topical eflornithine hydrochloride demonstrates efficacy in managing hirsutism.
- This topical treatment is devoid of systemic side effects.
Conclusions:
- Safer and more effective management options for hirsutism are needed.
- Topical eflornithine hydrochloride represents a significant advancement in hirsutism treatment.
- This medication addresses the need for localized therapy without systemic absorption.